We are pleased to announce a new Cambridge Proteomics and Mass Spectrometry (MS) Meeting will be held on Thursday 17th October at 12-5pm on the Babraham Research Campus. This meeting will feature talks, posters, and networking for both academics and companies in and around Cambridge.
Guest blog post by Domainex
Domainex launches a new webinar series, hosted by One Nucleus, to discuss the latest approaches and technologies that will be vital in any drug discovery programme.
Following the boom-and-bust years of Covid investment followed by economic challenges, the UK life science industry is still driving progress in drug discovery. But with the cost of medicines development continuing to soar, staying one step ahead in this competitive space is an ongoing challenge.
Clinical Science Liaison / Medical Affairs
– French and English-speaking
Location: Poland
Sandwich, Kent, UK / 24 September 2024 / A group of former Pfizer employees have successfully created their own businesses based at and supported by Discovery Park, a thriving life sciences community in Kent.
The Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate has today announced the first cohort of awardees of its Collaborative Discovery Programme (CDP) funding.
The £3 million programme, funded by LifeArc, will support six early-stage novel antimicrobial projects over two years to accelerate new treatments for lung infections in people with CF.
About the role
The role of the Commercialisation Manager is to support the Head of BDI in delivering Knowledge Exchange, Commercialisation, and Impact Strategies.
The main purpose of the job will be to drive commercialisation of our research, grow the entrepreneurial culture, and help the institute to secure new income.
The key aspects of the role fall into the following areas:
Cambridge, UK – September 20th 2024 - The Cambridge Crystallographic Data Centre (CCDC) is pleased to announce the integration of our industry-validated Genetic Optimization for Ligand Docking (GOLD) software with Cadence Molecular Sciences (OpenEye)’s Orion platform. This collaboration provides computational and medicinal chemists with a powerful new toolset to streamline and enhance their protein–ligand docking workflows on Cadence Molecular Sciences cloud-native Orion platform, a crucial step in pharmaceutical development.
Discovery Spark is a transformative innovation growth programme for early-stage companies, packed with invaluable resources and support. Across a number of in-person sessions led by seasoned professionals and industry leaders, participants will gain the essential skills needed to lay robust foundations in their business and prepare for investment. Discovery Spark is aimed at businesses across a diverse range of sectors including biotech, medtech, diagnostics and advanced therapies and those who have raised up to £1 million in equity.
Collaborative Drug Discovery Community Meeting brings the European technology and scientific communities together. This year is special as we are celebrating CDD's 20 years of excellence.
We invite you to join us to learn about the latest life science industry trends, discuss research data strategies on best practices with peers, explore CDD Vault, get personalized training, listen to engaging keynotes, and network with industry experts.
The distinguished line-up of speakers include: